Changes in the epidemiology and distribution of the hepatitis C virus genotypes in North-Eastern Spain over the last 35 years
- PMID: 29150360
- DOI: 10.1016/j.gastrohep.2017.09.004
Changes in the epidemiology and distribution of the hepatitis C virus genotypes in North-Eastern Spain over the last 35 years
Abstract
Background: Genotypic distribution and epidemiology of HCV infection in Western Europe countries has changed over the last decades.
Aim: To establish the local genotypic profile and characterize the associated demographic variables.
Material and method: All the genotyping from 1988 to 2015 were considered. Associated demographic variables were included in logistic regression models. Genotyping was carried out with updated commercial kits.
Results: Genotype 1b was the most prevalent (42.4%) followed by 1a (22.5%), 3 (18.6%), 4 (10.6%) and 2 (4.6%). The prevalence of 1a was higher in males, in patients younger than 45 and in intravenous drug users (IDU). 1b was more frequent in older than 45, with transfusion-associated and parenteral/nosocomial infections and in immigrants from Eastern Europe. Genotype 2 was highly prevalent in the postransfusional route (54.9%). Genotype 3 prevalence was high in males, in patients younger than 45, in IDU (69.3%) and in Asian and Eastern European immigrants. Genotype 4 was high in males, in patients younger than 45, and in IDU (63.5%). 1a, 3, 4 were the most prevalent genotypes in HIV-coinfected patients. There was a significant decline in genotype 1b and an increase in genotypes 3 and 4 over time.
Conclusions: There has been a decline of genotype 1b, associated with transfusion or parenteral/nosocomial infections, and increases in the prevalence of genotypes 1a, 3 and 4 associated with male gender and IDU, now the most prevalent infection route. Immigration contributed with genotype 2 infections from Africa and genotype 1b and 3 infections from Eastern Europe and Asia.
Keywords: Chronic hepatitis C; Epidemiology; Epidemiología; Genotipos; Genotypes; HCV; Hepatitis C crónica; Hepatitis C virus; VHC; Virus de la hepatitis C.
Copyright © 2017 Elsevier España, S.L.U. All rights reserved.
Similar articles
-
Epidemiological distribution and genotype characterization of hepatitis C virus and HIV co-infection in Wuhan, China, where the prevalence of HIV is low.J Med Virol. 2013 Oct;85(10):1712-23. doi: 10.1002/jmv.23650. Epub 2013 Jul 19. J Med Virol. 2013. PMID: 23868809
-
Epidemiology of hepatitis C virus and genotype distribution in immigrants crossing to Europe from North and sub-Saharan Africa.Travel Med Infect Dis. 2016 Sep-Oct;14(5):517-526. doi: 10.1016/j.tmaid.2016.05.020. Epub 2016 Aug 5. Travel Med Infect Dis. 2016. PMID: 27502972
-
Prevalence and distribution of hepatitis C virus genotypes in Spain during the 2000-2015 period (the GEHEP 005 study).J Viral Hepat. 2017 Sep;24(9):725-732. doi: 10.1111/jvh.12700. Epub 2017 Apr 10. J Viral Hepat. 2017. PMID: 28248445
-
Injecting drug use: A vector for the introduction of new hepatitis C virus genotypes.World J Gastroenterol. 2015 Oct 14;21(38):10811-23. doi: 10.3748/wjg.v21.i38.10811. World J Gastroenterol. 2015. PMID: 26478672 Free PMC article. Review.
-
Global epidemiology of hepatitis C virus infection: An up-date of the distribution and circulation of hepatitis C virus genotypes.World J Gastroenterol. 2016 Sep 14;22(34):7824-40. doi: 10.3748/wjg.v22.i34.7824. World J Gastroenterol. 2016. PMID: 27678366 Free PMC article. Review.
Cited by
-
Risk Factors Associated with Hepatitis C Subtypes and the Evolutionary History of Subtype 1a in Mexico.Viruses. 2024 Aug 6;16(8):1259. doi: 10.3390/v16081259. Viruses. 2024. PMID: 39205233 Free PMC article.
-
Seroprevalence and epidemiology of hepatitis B and C viruses in pregnant women in Spain. Risk factors for vertical transmission.PLoS One. 2020 May 21;15(5):e0233528. doi: 10.1371/journal.pone.0233528. eCollection 2020. PLoS One. 2020. PMID: 32437468 Free PMC article.
-
Epidemic history and baseline resistance to NS5A-specific direct acting drugs of hepatitis C virus in Spain.Sci Rep. 2020 Aug 3;10(1):13024. doi: 10.1038/s41598-020-69692-7. Sci Rep. 2020. PMID: 32747734 Free PMC article.
-
Real-world evidence of the effectiveness of ombitasvir-paritaprevir/r ± dasabuvir ± ribavirin in patients monoinfected with chronic hepatitis C or coinfected with human immunodeficiency virus-1 in Spain.PLoS One. 2019 Nov 12;14(11):e0225061. doi: 10.1371/journal.pone.0225061. eCollection 2019. PLoS One. 2019. PMID: 31714950 Free PMC article.
-
Impact of successful treatment with direct-acting antiviral agents on health-related quality of life in chronic hepatitis C patients.PLoS One. 2018 Oct 9;13(10):e0205277. doi: 10.1371/journal.pone.0205277. eCollection 2018. PLoS One. 2018. PMID: 30300395 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical